EQ-5D and the EuroQol Group: Past, Present and Future.
EQ-5D and the EuroQol Group: Past, Present and Future.
复制标题
DOI：
10.1007/s40258-017-0310-5
复制
发表时间：
2017-04
影响因子：
3.6
通讯作者：
Brooks R
中科院分区：
文献类型：
--
作者：
Devlin NJ;Brooks R
在1987年至1991年期间，一个跨学科的五国小组开发了EuroQol工具，这是一种五维三级通用测量，后来被称为“EQ-5D”。它旨在衡量和评价健康状况。论述了其发展的显著特点及其巩固和发展。最初的扩充特别是以新语文版本的形式进行的。他们的发展提出了翻译和语义问题，经验有助于进一步设计两个仪器，EQ-5D-5L和青年版EQ-5D-Y。概述了在临床项目、疾病和病症领域、人口调查、患者报告的结果和值集之间的扩展使用。估值对本集团持续具有相关性，因为这使其工具可用作健康计划的经济评估的一部分，并将其纳入健康技术评估。本集团的未来是在以下背景下考虑的：（1）其科学战略，（2）影响EQ-5D需求的外部环境变化，以及（3）其在仪器设计、其在健康技术评估中的使用以及EQ-5D在临床试验和技术评估之外的潜在新用途方面面临的各种问题。本文的在线版本（doi：10.1007/s40258-017-0310-5）包含补充材料，可供授权用户使用。
Over the period 1987–1991 an inter-disciplinary five-country group developed the EuroQol instrument, a five-dimensional three-level generic measure subsequently termed the ‘EQ-5D’. It was designed to measure and value health status. The salient features of its development and its consolidation and expansion are discussed. Initial expansion came, in particular, in the form of new language versions. Their development raised translation and semantic issues, experience with which helped feed into the design of two further instruments, the EQ-5D-5L and the youth version EQ-5D-Y. The expanded usage across clinical programmes, disease and condition areas, population surveys, patient-reported outcomes, and value sets is outlined. Valuation has been of continued relevance for the Group as this has allowed its instruments to be utilised as part of the economic appraisal of health programmes and their incorporation into health technology assessments. The future of the Group is considered in the context of: (1) its scientific strategy, (2) changes in the external environment affecting the demand for EQ-5D, and (3) a variety of issues it is facing in the context of the design of the instrument, its use in health technology assessment, and potential new uses for EQ-5D outside of clinical trials and technology appraisal. The online version of this article (doi:10.1007/s40258-017-0310-5) contains supplementary material, which is available to authorized users.